RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Dallas, TX · Fort Worth, TX · +48 more sites
6 recruiting lupus studies with a site in Dallas, TX.
Sponsor: National Cancer Institute (NCI)
Dallas, TX · Fort Worth, TX · +48 more sites
Sponsor: Fate Therapeutics
Dallas, TX · +11 more sites
Sponsor: Aurinia Pharmaceuticals Inc.
Bellaire, TX · Dallas, TX · El Paso, TX · +24 more sites
Sponsor: GlaxoSmithKline
Dallas, TX · +5 more sites
Sponsor: Nkarta, Inc.
Dallas, TX · Houston, TX · +15 more sites
Sponsor: Lupus Research Alliance
Dallas, TX · +18 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.